Australian biotech market today 23.04.09
Thursday, 23 April, 2009
A very flat day’s trading on the healthcare index today, in line with the rest of stocks, which were generally in the positive but volumes were small.
Biota (ASX:BTA) is up 12c on news that royalties from Relenza for the quarter will total $32.3 million.
Circadian (ASX:CIR) was up 3c, as was Clinuvel (ASX:CLV), up 2c to 32c.
Cochlear (ASX:COH) was substantially down again, to $48.3, while Pharmaxis (ASX:PXS) was up a touch.
Diversa (ASX:DVA) was up slightly on its reinstatement to trading.
Less penicillin needed to treat Strep A infection than we thought
It's never been known exactly how much penicillin prevents sore throats — the most...
Stress disrupts emotion control in mental illness
Acute stress may impair key brain functions involved in managing emotions — particularly in...
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...